The global regenerative medicine market size
is expected to reach USD 5.59 billion by 2025, according to a new report by
Grand View Research, Inc. Increased prevalence of neurodegenerative,
orthopedic, and other aging-related disorders in geriatric population coupled
with rising global geriatric population is anticipated to drive market growth.
Developments in
biotechnology have enabled gaining in-depth knowledge pertaining to cell division
and differentiation as well as the metabolism mechanism of various cells. This
enriched knowledge, coupled with emergence of novel streams of biotechnology
such as gene therapy and nanotechnology, further prospered use of cell-based
technology in therapeutic treatment.
Well established
regenerative approached for various dermatological indications exists since
ages. Technological advances introduced scaffolds, matrices, and grafts
engineered for faster regeneration and minimal surgical procedure.
Identification of
ability of stem cells to develop into various different cell lines further
propelled the advancements in regenerative medicine. Frequent media exposure
due to regulatory as well as ethical controversies around embryonic stem cells
has increased awareness among the masses. This encouraged researchers to
explore and develop other potential fields for similar applications, such as
induced pluripotent stem cells (iPSC).
Furthermore, the
emergence of gene therapy techniques with potential to rectify and restore
effects of gene mutations in cells is under development. Conditions caused due
to Single Nucleotide Polymorphism (SNP) as well as mutations that induce
degenerative characteristics are primarily targeted.
Biologics, individually
or in combination with cells or devices, are explored to support regenerate the
biological functions of cells, tissues, or organs. A number of combinatorial
therapies to support chemotherapy and other cancer treatments by prevention as
well as treatment for cancer relapse are in development phases.
In addition, rising
prevalence of complicated degenerative disorders such as age-related macular
degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the
aging population resulted in high investments in R&D to develop therapeutic
solutions.
Regenerative medicine
grabs the attention of the healthcare industry owing to its promising
applications along with significant advances in supportive fields including
tissue engineering, stem cells, gene therapy, drug discovery and
nanotechnology. For instance, 3D printing over scaffold with stem cells to
restore structure as well as functional characteristics of biological cells,
tissues, and organs.
Browse full report by Grand View
Research :
Further key findings from the report suggest:
·
The global regenerative medicine demand
exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate
over the forecast period owing to the presence of a strong looking product
pipeline with anticipated commercializations just around the corner
·
Therapeutics emerged as the largest product
segment in 2016 as it has a relatively high implementation and usage rate
resulting in higher adoption
·
Global regenerative services demand for
facilities such as tissue banks and cellular engineering tools is expected to
drive demand in the segment
·
The industry in Asia Pacific is projected
to witness substantial growth over the next decade owing to various
developments across major economies with increased focus of dominant players in
emerging economies is attributive to market growth. market.
·
Key players including Asterias Bio,
Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex
technical cum financial partnerships with larger players in an attempt to
expedite R&D
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has
segmented the global regenerative medicine market on the basis of product,
therapeutic category, and region:
Regenerative Medicine Product Outlook (Revenue, USD
Million, 2014 - 2025)
·
Therapeutics & Devices
o Primary Cell-bases therapeutics
o Dermatology
o Musculoskeletal
o Surgical
o Dental
o Others
o Stem Cell & Progenitor Cell-based therapeutics
o Autologous
o Allogeneic
o Others
o Tools
o Banks
o Services
Regenerative Medicine Therapeutic Category Outlook
(Revenue, USD Million, 2014 - 2025)
·
Dermatology
·
Musculoskeletal
·
Immunology & Inflammation
·
Oncology
·
Cardiovascular
·
Ophthalmology
·
Others
Regenerative Medicine Regional Outlook (Revenue, USD
Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o China
o Japan
·
Latin America
o Brazil
·
Middle East & Africa
o South Africa
Access
press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-regenerative-medicine-market
About
Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment